Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence

Lilly

Status and phase: Completed; Phase 3

Conditions: Urinary Incontinence, Stress

Treatments: Drug: placebo; Drug: Duloxetine Hydrochloride

Study type: Interventional

Funder types: Industry

Identifiers

NCT00190996

F1J-EW-SBCC

8049

Details and patient eligibility

About

The purposes of this study are to determine whether duloxetine can help subjects with stress urinary incontinence and to see whether the effects of duloxetine can be maintained.

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female diagnosed with stress urinary incontinence

Exclusion criteria

• Currently taking a monoamine oxidase inhibitor

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind